Back to search
FDAFDA · Food and drugs·Recall number D-0008-2015

Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01

Published October 15, 2014 · Recall initiated: September 15, 2014

Summary

FDA records drug Class II recall D-0008-2015, published October 15, 2014 and initiated September 15, 2014. Recalling firm: Astellas Pharma US Inc; Status: Terminated; Reported quantity: 9,236 bottles; Lot: Lot 66482CW, Exp 04/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Astellas Pharma US Inc
Distributor
Nationwide
Lot
Lot 66482CW, Exp 04/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tarceva (erlotinib) Tablets, 150 mg, 30 count bottle, Rx only, Manufactured by: Kremers Urban Pharmaceuticals Inc. Seymour, IN 47274 NDC 50242-064-01 recalled?

Yes. FDA published recall D-0008-2015 on October 15, 2014. Reported hazard: Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter